Amneal Pharmaceuticals (AMRX) insider trading in the last 6 months

3 insiders sold $7.2M. No buys.

Quality Score19Excellent

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

See all 4 tradesSee it live, free until Thursday morning. No account. No card. Then keep going with a free account.

Form 4 filings, newest first

SellJohn Kiely$882KDirectorat $17.64 on Aug 13, filed Aug 14

SellJohn KielyDirector$882Kat $17.64 on Aug 13, filed Aug 14

SellJason B. Daly$3.7MEVP, Chief Legal Officerat $17.40 on Aug 12, filed Aug 13

SellJason B. DalyEVP, Chief Legal Officer$3.7Mat $17.40 on Aug 12, filed Aug 13

SellNikita Shah$2.6MExecutive Vice Presidentat $17.51 on Aug 12, filed Aug 13

SellNikita ShahExecutive Vice President$2.6Mat $17.51 on Aug 12, filed Aug 13

From SEC Form 4s, the newest filed Aug 14, 2026 · Insiders have 2 business days to file a trade

Pro members see every filing on AMRX with what each insider bought or sold and at what price, and can turn on an optional alert when an insider buys.

Who files at Amneal Pharmaceuticals

Insider trades by person

Tested. Our top-scored stocks returned 2.2x the average stock over the next month. Reconstructed after the fact; recorded live since Sep 9, 2026. How we tested it

Questions about AMRX's insider trades

As of Nov 10, 2026: Amneal Pharmaceuticals (AMRX) has 4 insider filings on record in the last 6 months, the newest filed Aug 14, 2026. Its Quality Score is 19 (Excellent). Scores as of 11:35 PM ET, 15 minutes behind.

Are AMRX insiders buying or selling?

3 insiders sold $7.2M across 4 filings in the last 6 months. No open-⁠market buys on record. The newest filing: John Kiely, Director, sold $882K on Aug 13, 2026.

Who are AMRX's biggest insider sellers?

By the dollars of their sales in the last 6 months: Jason B. Daly (EVP, Chief Legal Officer), 2 sales; Nikita Shah (Executive Vice President), 1 sale; John Kiely (Director), 1 sale.

When did an AMRX insider last buy?

No AMRX insider bought shares on the open market in the last 6 months, as filed on Form 4. The newest filing is a sale by John Kiely on Aug 13, 2026.

Amneal Pharmaceuticals's page has its Quality Score, its chart, and its earnings. More in Healthcare and Biotech.

Amneal Pharmaceuticals (AMRX) insider trading in the last 6 months

Form 4 filings, newest first

Who files at Amneal Pharmaceuticals

Questions about AMRX's insider trades

Every insider trade, with its stock's score.